Corporate Leadership

Corporate Leadership

Medex15 is founded in 2015 by Lisette Stork-Sloots and Femke de Snoo, Medical Experts who combined have everything it takes to make your medical or clinical project a success. We are flexible, quick, result oriented, cost-effective and accurate. We have worked together for many years in the oncology field. We have experienced our collaborators to be highly appreciative of our joined expertise. We have a long list of peer reviewed publications and an extensive clinical trial portfolio. Our approach requires no separate investment in clinical trial expertise or medical advice. We offer a unique combination of medical due diligence, a hands-on approach and a team of experienced statisticians, CRA’s, medical writers and legal counselors. Importantly, we have a global network of key opinion leaders in oncology.

Femke de Snoo, MD PhD, President and co-founder of Medex15

Femke earned her medical degree followed by a PhD in Clinical Genetics. She gained extensive experience in performing translational research in an international setting at the University of Pennsylvania, at the genetics research department at the LUMC and at the National Human Genome Research Institute at NIH in Bethesda. Femke has extensive experience with cancer patients in the oncogenetic setting and has been involved in multiple clinical research projects. At Agendia -a molecular diagnostics company known for the MammaPrint test- she was as the senior Director Medical Affairs, the liaison between physicians, scientists, and the marketing and sales department.

Lisette Stork-Sloots, MSc, President and co-founder of Medex15

Lisette has 20 years global clinical research experience in Phase 1-4 drug and molecular diagnostic studies. She worked several years at the headquarters of Eli Lilly leading the European oncology clinical development team and as a global program manager for assigned drug development programs (preclinical, phase 1 and 2). At Agendia –a molecular diagnostics company known for the MammaPrint test- she implemented the clinical affairs department and designed, implemented and managed global clinical trials.